Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041101 | SCV000064792 | likely benign | not specified | 2012-01-24 | criteria provided, single submitter | clinical testing | Arg4091Lys in exon 45B of TTN: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (12/3118) of African American c hromosomes by the NHLBI Exome Sequencing Project in a broad population (http://e vs.gs.washington.edu/EVS). Arg4091Lys in exon 45B of TTN (allele frequency = 0. 4%, 12/3118) ** |
Gene |
RCV001703923 | SCV000238181 | likely benign | not provided | 2020-03-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000247432 | SCV000320092 | likely benign | Cardiovascular phenotype | 2018-08-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000041101 | SCV000333897 | likely benign | not specified | 2015-08-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000472841 | SCV000555634 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000041101 | SCV000615990 | benign | not specified | 2016-10-28 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001703923 | SCV002049383 | likely benign | not provided | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839821 | SCV002100814 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839822 | SCV002100815 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839823 | SCV002100816 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839820 | SCV002100817 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004537141 | SCV004721057 | likely benign | TTN-related disorder | 2021-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000041101 | SCV001978949 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001703923 | SCV001979860 | likely benign | not provided | no assertion criteria provided | clinical testing |